Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Lancet Oncol. 2023 Sep;24(9):1029-1041. doi: 10.1016/S1470-2045(23)00268-1.
Lancet Oncol. 2023.
PMID: 37657462
Free article.
Clinical Trial.
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
de Haas SL, Slamon DJ, Martin M, Press MF, Lewis GD, Lambertini C, Prat A, Lopez-Valverde V, Boulet T, Hurvitz SA.
de Haas SL, et al. Among authors: lopez valverde v.
Breast Cancer Res. 2023 Jan 11;25(1):2. doi: 10.1186/s13058-022-01587-z.
Breast Cancer Res. 2023.
PMID: 36631725
Free PMC article.
Clinical Trial.
Item in Clipboard
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, Wildiers H, Campone M, Boileau JF, Fasching PA, Afenjar K, Spera G, Lopez-Valverde V, Song C, Trask P, Boulet T, Sparano JA, Symmans WF, Thompson AM, Slamon D.
Hurvitz SA, et al. Among authors: lopez valverde v.
J Clin Oncol. 2019 Sep 1;37(25):2206-2216. doi: 10.1200/JCO.19.00882. Epub 2019 Jun 3.
J Clin Oncol. 2019.
PMID: 31157583
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors.
Leijen S, Middleton MR, Tresca P, Kraeber-Bodéré F, Dieras V, Scheulen ME, Gupta A, Lopez-Valverde V, Xu ZX, Rueger R, Tessier JJ, Shochat E, Blotner S, Naegelen VM, Schellens JH, Eberhardt WE.
Leijen S, et al. Among authors: lopez valverde v.
Clin Cancer Res. 2012 Sep 1;18(17):4794-805. doi: 10.1158/1078-0432.CCR-12-0868. Epub 2012 Jul 5.
Clin Cancer Res. 2012.
PMID: 22767668
Clinical Trial.
Item in Clipboard
Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery.
Stankevicius E, Lopez-Valverde V, Rivera L, Hughes AD, Mulvany MJ, Simonsen U.
Stankevicius E, et al. Among authors: lopez valverde v.
Br J Pharmacol. 2006 Nov;149(5):560-72. doi: 10.1038/sj.bjp.0706886. Epub 2006 Sep 11.
Br J Pharmacol. 2006.
PMID: 16967048
Free PMC article.
Item in Clipboard
Glibenclamide reveals role for endothelin in hypoxia-induced vasoconstriction in rat intrapulmonary arteries.
López-Valverde V, Andersen CU, Laursen BE, Mulvany MJ, Simonsen U.
López-Valverde V, et al.
J Cardiovasc Pharmacol. 2005 Oct;46(4):422-9. doi: 10.1097/01.fjc.0000175877.25296.bd.
J Cardiovasc Pharmacol. 2005.
PMID: 16160592
Item in Clipboard
Cite
Cite